These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2471850)

  • 21. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of proglumide on rat pancreatic growth.
    Yamaguchi T; Tabata K; Johnson LR
    Am J Physiol; 1985 Aug; 249(2 Pt 1):G294-8. PubMed ID: 2411150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duration of anti-cholecystokinin (CCK) action on the rat exocrine pancreas of new CCK receptor antagonist FK480 administered orally.
    Moriyoshi Y; Shiratori K; Iwabe C; Watanabe S; Takeuchi T
    J Gastroenterol; 1996 Apr; 31(2):249-53. PubMed ID: 8680546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioactivity of synthetic human cholecystokinin (CCK)-33 in vitro and in vivo.
    Shinozaki H; Miyasaka K; Wakasugi H; Fujii N; Funakoshi A
    Gastroenterol Jpn; 1991 Feb; 26(1):51-5. PubMed ID: 1706670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormonal mechanism of sodium oleate-stimulated pancreatic secretion in rats.
    Li P; Lee KY; Chang TM; Chey WY
    Am J Physiol; 1990 Dec; 259(6 Pt 1):G960-5. PubMed ID: 2260665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
    Niederau C; Liddle RA; Williams JA; Grendell JH
    Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of loxiglumide on pancreatic exocrine secretion stimulated by meal in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Edano K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):55-7. PubMed ID: 9522033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
    Louie DS; Liang JP; Owyang C
    Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proglumide inhibits cholecystokinin and meal-stimulated pancreatic secretion and release of pancreatic polypeptide.
    Beauchamp RD; Gomez G; Nealon WH; Townsend CM; Greeley GH; Thompson JC
    Surgery; 1990 Sep; 108(3):553-8. PubMed ID: 2396199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.
    Makovec F; Bani M; Cereda R; Chisté R; Pacini MA; Revel L; Rovati LA; Rovati LC; Setnikar I
    Arzneimittelforschung; 1987 Nov; 37(11):1265-8. PubMed ID: 3440035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of endogenous CCK in regulation of interdigestive pancreatic exocrine secretion in sheep (Ovis aries).
    Tachibana S; Onaga T; Mineo H; Kato S
    Comp Biochem Physiol A Physiol; 1995 Sep; 112(1):103-9. PubMed ID: 7553326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic CCK8 analogs with antagonist activity on pancreatic receptors: in vivo study in the rat, compared to non-peptidic antagonists.
    Nagain C; Galas MC; Lignon MF; Rodriguez M; Martinez J; Rozé C
    Pancreas; 1991 May; 6(3):275-81. PubMed ID: 1713671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of long-term administration of lorglumide (CR 1409) on rat pancreatic growth and enzyme composition.
    Takács T; Nagy I; Pap A; Varró V
    Pancreas; 1990 Sep; 5(5):606-10. PubMed ID: 1700417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New proglumide-analogue CCK receptor antagonists: very potent and selective for peripheral tissues.
    Niederau C; Niederau M; Williams JA; Grendell JH
    Am J Physiol; 1986 Jun; 250(6 Pt 1):G856-60. PubMed ID: 2424321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cisapride on the pancreatic exocrine secretion in rats.
    Funakoshi A; Miyasaka K; Shinozaki H; Kitani K
    Gastroenterol Jpn; 1988 Oct; 23(5):559-63. PubMed ID: 3215439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of intraduodenal oligopeptide on rat pancreatic exocrine secretion and release of secretin and CCK].
    Shimizu K
    Nihon Shokakibyo Gakkai Zasshi; 1990 Nov; 87(11):2509-16. PubMed ID: 1703583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The inhibitory effect of CR-1409 on amylase secretion and intracellular Ca2+ mobilization in rat pancreatic acini in vitro.
    Shinozaki H; Funakoshi A; Wakasugi H; Abe M
    Jpn J Physiol; 1989; 39(4):585-93. PubMed ID: 2481056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of deramciclane, a new 5-HT receptor antagonist, on cholecystokinin-induced changes in rat gastrointestinal function.
    Varga G; Kordás K; Burghardt B; Gacsályi I; Szénási G
    Eur J Pharmacol; 1999 Feb; 367(2-3):315-23. PubMed ID: 10079007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of cholecystokinin in pancreatic exocrine response to intraluminal amino acids and fat.
    Stubbs RS; Stabile BE
    Am J Physiol; 1985 Mar; 248(3 Pt 1):G347-52. PubMed ID: 2858160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
    Gabryelewicz A; Kulesza E; Konturek SJ
    Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.